Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Medical Minute 1: Endogenous Incretins
  • CME
  • CE

Medical Minute 2: Multisystemic Actions of GIP/GLP-1 Coagonists
Credits Available
Physicians: maximum of 0.25 AMA PRA Category 1 Credits
Registered Nurses: 0.25 Nursing contact hours
Pharmacists: 0.25 contact hours (0.025 CEUs)
Registered Dieticians/Dietetic Technicians, Registered: maximum of 0.25 CPEU(s)
Released: August 9, 2021 Expiration: August 8, 2022
Start Activity
Provided by Clinical Care Options

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Endocrine Society Logo
Supported by an educational grant from
Lilly
Carol Hatch Wysham, MD

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Describe the physiologic effects of incretins on the gastrointestinal tract and the impact of these effects on multiple systems

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty

Carol Hatch Wysham, MD

Clinical Professor of Medicine
University of Washington
Rockwood Center for Diabetes and Endocrinology
Rockwood Clinic/MultiCare Health System
Spokane, Washington

Carol Hatch Wysham, MD, has disclosed that she has received funds for research support from Abbot, Allergan, Lilly, and Novo Nordisk; consulting fees from Abbott, Janssen, Novo Nordisk, and Sanofi; and fees for non-CME/CE services from AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Sanofi.

Staff

Kiran D. Mir-Hudgeons, PhD

Manager, Editorial Operations

Kiran D. Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.
Ruth Cohen Cooper, CHCP

Vice President, Science and Strategy

Ruth Cohen Cooper, CHCP, has no relevant conflicts of interest to report.
Julie Skowronski, FNP-BC
Julie Skowronski, MSN, FNP-BC has no relevant conflicts of interest to report.
Nicole Cunningham, MS, RD, CDE
Nicole Cunningham, MS, RD, CDE has no relevant conflicts of interest to report.
Robin Black, PharmD, BCACP

Scientific Director

Robin Black, PharmD, BCACP, has no relevant conflicts of interest to report.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for endocrinologists, primary care physicians, nurses, advanced practice clinicians, pharmacists, dieticians, and other HCPs who care for patients with T2D, obesity, and/or dyslipidemia.

Goal

The goal of this activity is to improve learners’ competence in navigating the most challenging clinical issues related to patients with T2D and cardiometabolic disease in order to provide holistic care and improve patient outcomes.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 contact hours.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 0.25 contact hours (.025 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-21-141-H01-P.

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 100% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Registered Dieticians/Dietetic Technicians, Registered

Credit Designation

Registered Dieticians and Dietetic Technicians, Registered will receive 0.25 Continuing Professional Education units (CPEUs) for completion of this activity.

Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs are to select activity type 102 in their Activity Log. Performance Indicator selection is at the learner’s discretion.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 09, 2021, through August 08, 2022:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Medical Minute 1: Endogenous Incretins
  • CME
  • CE

Medical Minute 2: Multisystemic Actions of GIP/GLP-1 Coagonists
Loading...
In this concise Medical Minute video, become familiar with incretins and review how currently available GLP-1 receptor agonists target multiple pathophysiologic defects in T2D.
Carol Hatch Wysham, MD
Physicians: maximum of 0.25 AMA PRA Category 1 Credits
Registered Nurses: 0.25 Nursing contact hours
Pharmacists: 0.25 contact hours (0.025 CEUs)
Registered Dieticians/Dietetic Technicians, Registered: maximum of 0.25 CPEU(s)
Released: August 9, 2021 Expiration: August 8, 2022

Related Content

From Dr. Carol Hatch Wysham and Clinical Care Options (CCO), expert commentary on emerging data on tirzepatide for type 2 diabetes

Carol Hatch Wysham, MD Released: September 21, 2021

This is the snippet that appears below the blue link in Google search. Words that matched the user query get pulled out in bold. From Clinical Care Options (CCO) and Dr. Ananda Basu, a brief commentary on barriers to use of diabetes technology

Ananda Basu, MD, FRCP Released: September 15, 2021

Downloadable slides from Clinical Care Options (CCO) featuring expert insights on the clinical trial data supporting the use of tirzepatide in T2D

Carol Hatch Wysham, MD Released: September 2, 2021

Short video from Clinical Care Options (CCO) featuring expert insights on the clinical trial data supporting the use of tirzepatide in T2D

Carol Hatch Wysham, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Registered Dieticians/Dietetic Technicians, Registered: maximum of 0.25 CPEU(s) Released: September 2, 2021 Expired: September 1, 2022
Provided by Clinical Care Options

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Endocrine Society Logo
Supported by an educational grant from
Lilly

For further information concerning Lilly grant funding visit www.lillygrantoffice.com

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue